Please see link below for information on donation waste in Pakistan<br><br>
<div class="gmail_quote">---------- Forwarded message ----------<br>From: <b class="gmail_sendername">Waqas Ahmed</b> <span dir="ltr"><<a href="mailto:waqaspharmacist@gmail.com">waqaspharmacist@gmail.com</a>></span><br>
Date: Tue, Sep 14, 2010 at 7:41 AM<br>Subject: [e-drug] Essential medicines management during emergencies in Pakistan<br>To: <a href="mailto:e-drug@healthnet.org">e-drug@healthnet.org</a><br><br><br>E-DRUG: Essential medicines management during emergencies in Pakistan<br>
------------------------------------------------------<br><br>S.K.S. Bukhari,1 J.A.R.H. Qureshi,1 R. Jooma,2 K.M. Bile,1 G.N.<br>Kazi,1 W.A. Zaibi1 and A. Zafar1<br><br>1World Health Organization, Country Office, Pakistan<br>
(Correspondence to S.K.S. Bukhari: <a href="mailto:bukharik@pak.emro.who.int">bukharik@pak.emro.who.int</a>). 2Ministry of<br>Health, Islamabad, Pakistan.<br><br>Abstract<br>This paper illustrates the experiences of essential medicine<br>
management in providing cure and care to victims of Pakistan’s 2005<br>earthquake in a safe, rational and effective mode. The health interventions<br>assured access to essential medicine, sustained supply, inventory control<br>
through a computerized logistic support system and rational use of<br>medicines. World Health Organization Pakistan outlined modalities for<br>acceptance of donated medicines, assisted in speedy procurement of medicines and designed custom-made kits. Proper storage of medicines at controlled temperature was ensured in warehousing facilities in 12 locations. A steady supply of medicines and their consumption without stock-outs in the 56 first-level care facilities of calamity-hit areas helped to ascertain the average consumption and cost of essential medicines and supplies for the catchment population. Tools for quantification and forecasting of medicines and supplies were developed and shared. Medicines and medical supplies were efficiently used resulting in minimum wastage.<br>
<br>Full Article is available on<br><a href="http://www.emro.who.int/publications/emhj/16_Supp/article14.htm" target="_blank">http://www.emro.who.int/publications/emhj/16_Supp/article14.htm</a><br><br>Waqas Ahmed<br><a href="mailto:waqaspharmacist@gmail.com">waqaspharmacist@gmail.com</a><br>
<br>_______________________________________________<br>Post message: <a href="mailto:e-drug@healthnet.org">e-drug@healthnet.org</a><br>Subscribe: <a href="mailto:e-drug-join@healthnet.org">e-drug-join@healthnet.org</a><br>
Unsubscribe: <a href="mailto:e-drug-leave@healthnet.org">e-drug-leave@healthnet.org</a><br>Help: <a href="mailto:e-drug-owner@healthnet.org">e-drug-owner@healthnet.org</a><br>Info & archives: <a href="http://list.healthnet.org/mailman/listinfo/e-drug" target="_blank">http://list.healthnet.org/mailman/listinfo/e-drug</a><br>
</div><br><br clear="all"><br>-- <br>
<div>Stevan Gressitt, M.D.<br>Faculty Associate, University of Maine Center on Aging<br>Academic Member, Athens Institute for Education and Research</div>
<div>Athens, Greece</div>
<div>Founding Director, Institute for Medicine Safety<br>University of New England, College of Pharmacy<br>Department of Pharmaceutical Sciences <br>Associate Professor of Clinical Psychiatry<br>University of New England, College of Osteopathic Medicine<br>
716 Stevens Avenue <br>Portland, Maine 04103<br><a href="mailto:gressitt@gmail.com" target="_blank">gressitt@gmail.com</a> <br>Cell: 207-441-0291 </div>
<div><a href="http://www.benzos.une.edu/" target="_blank">www.benzos.une.edu</a> </div>
<div><a href="http://www.safemeddisposal.com/" target="_blank">www.safemeddisposal.com/</a><br><br></div><br>